Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
The global Single-cell Transcriptome Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Single-cell Transcriptome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single-cell Transcriptome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Single-cell Transcriptome Sequencing in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Single-cell Transcriptome Sequencing include Aksomics, 10x Genomics, BD, BGI, Singleron Bio, Seekgene, ThunderBio, Tenk Genomics, MobiDrop, BioMarker, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single-cell Transcriptome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-cell Transcriptome Sequencing.
The Single-cell Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single-cell Transcriptome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-cell Transcriptome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Aksomics
10x Genomics
BD
BGI
Singleron Bio
Seekgene
ThunderBio
Tenk Genomics
MobiDrop
BioMarker
Dynamic Biosystems
M20 Genomics
Illumina
QIAGEN
Q2 Solutions
Novogene
Oxford Nanopore Technologies
PacBio
Azenta Life Sciences
Jingxin Biotechnology
TaKaRa
Bio-Rad
Mission bio
Segment by Type
Equipment
Serve
Segment by Application
Cancer
Immunology
Neurology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single-cell Transcriptome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Single-cell Transcriptome Sequencing 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment
1.2.3 Serve
1.3 麻豆原创 by Application
1.3.1 Global Single-cell Transcriptome Sequencing 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Immunology
1.3.4 Neurology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single-cell Transcriptome Sequencing 麻豆原创 Perspective (2019-2030)
2.2 Global Single-cell Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Single-cell Transcriptome Sequencing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Single-cell Transcriptome Sequencing Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Single-cell Transcriptome Sequencing Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Single-cell Transcriptome Sequencing 麻豆原创 Dynamics
2.3.1 Single-cell Transcriptome Sequencing Industry Trends
2.3.2 Single-cell Transcriptome Sequencing 麻豆原创 Drivers
2.3.3 Single-cell Transcriptome Sequencing 麻豆原创 Challenges
2.3.4 Single-cell Transcriptome Sequencing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single-cell Transcriptome Sequencing Players by Revenue
3.1.1 Global Top Single-cell Transcriptome Sequencing Players by Revenue (2019-2024)
3.1.2 Global Single-cell Transcriptome Sequencing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Single-cell Transcriptome Sequencing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Single-cell Transcriptome Sequencing Revenue
3.4 Global Single-cell Transcriptome Sequencing 麻豆原创 Concentration Ratio
3.4.1 Global Single-cell Transcriptome Sequencing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single-cell Transcriptome Sequencing Revenue in 2023
3.5 Global Key Players of Single-cell Transcriptome Sequencing Head office and Area Served
3.6 Global Key Players of Single-cell Transcriptome Sequencing, Product and Application
3.7 Global Key Players of Single-cell Transcriptome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Single-cell Transcriptome Sequencing Breakdown Data by Type
4.1 Global Single-cell Transcriptome Sequencing Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Single-cell Transcriptome Sequencing Forecasted 麻豆原创 Size by Type (2025-2030)
5 Single-cell Transcriptome Sequencing Breakdown Data by Application
5.1 Global Single-cell Transcriptome Sequencing Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Single-cell Transcriptome Sequencing Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Single-cell Transcriptome Sequencing 麻豆原创 Size (2019-2030)
6.2 North America Single-cell Transcriptome Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2019-2024)
6.4 North America Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single-cell Transcriptome Sequencing 麻豆原创 Size (2019-2030)
7.2 Europe Single-cell Transcriptome Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2019-2024)
7.4 Europe Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single-cell Transcriptome Sequencing 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Single-cell Transcriptome Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Single-cell Transcriptome Sequencing 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Single-cell Transcriptome Sequencing 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single-cell Transcriptome Sequencing 麻豆原创 Size (2019-2030)
9.2 Latin America Single-cell Transcriptome Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single-cell Transcriptome Sequencing 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Single-cell Transcriptome Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aksomics
11.1.1 Aksomics Company Details
11.1.2 Aksomics Business Overview
11.1.3 Aksomics Single-cell Transcriptome Sequencing Introduction
11.1.4 Aksomics Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.1.5 Aksomics Recent Development
11.2 10x Genomics
11.2.1 10x Genomics Company Details
11.2.2 10x Genomics Business Overview
11.2.3 10x Genomics Single-cell Transcriptome Sequencing Introduction
11.2.4 10x Genomics Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.2.5 10x Genomics Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Single-cell Transcriptome Sequencing Introduction
11.3.4 BD Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.3.5 BD Recent Development
11.4 BGI
11.4.1 BGI Company Details
11.4.2 BGI Business Overview
11.4.3 BGI Single-cell Transcriptome Sequencing Introduction
11.4.4 BGI Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.4.5 BGI Recent Development
11.5 Singleron Bio
11.5.1 Singleron Bio Company Details
11.5.2 Singleron Bio Business Overview
11.5.3 Singleron Bio Single-cell Transcriptome Sequencing Introduction
11.5.4 Singleron Bio Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.5.5 Singleron Bio Recent Development
11.6 Seekgene
11.6.1 Seekgene Company Details
11.6.2 Seekgene Business Overview
11.6.3 Seekgene Single-cell Transcriptome Sequencing Introduction
11.6.4 Seekgene Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.6.5 Seekgene Recent Development
11.7 ThunderBio
11.7.1 ThunderBio Company Details
11.7.2 ThunderBio Business Overview
11.7.3 ThunderBio Single-cell Transcriptome Sequencing Introduction
11.7.4 ThunderBio Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.7.5 ThunderBio Recent Development
11.8 Tenk Genomics
11.8.1 Tenk Genomics Company Details
11.8.2 Tenk Genomics Business Overview
11.8.3 Tenk Genomics Single-cell Transcriptome Sequencing Introduction
11.8.4 Tenk Genomics Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.8.5 Tenk Genomics Recent Development
11.9 MobiDrop
11.9.1 MobiDrop Company Details
11.9.2 MobiDrop Business Overview
11.9.3 MobiDrop Single-cell Transcriptome Sequencing Introduction
11.9.4 MobiDrop Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.9.5 MobiDrop Recent Development
11.10 BioMarker
11.10.1 BioMarker Company Details
11.10.2 BioMarker Business Overview
11.10.3 BioMarker Single-cell Transcriptome Sequencing Introduction
11.10.4 BioMarker Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.10.5 BioMarker Recent Development
11.11 Dynamic Biosystems
11.11.1 Dynamic Biosystems Company Details
11.11.2 Dynamic Biosystems Business Overview
11.11.3 Dynamic Biosystems Single-cell Transcriptome Sequencing Introduction
11.11.4 Dynamic Biosystems Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.11.5 Dynamic Biosystems Recent Development
11.12 M20 Genomics
11.12.1 M20 Genomics Company Details
11.12.2 M20 Genomics Business Overview
11.12.3 M20 Genomics Single-cell Transcriptome Sequencing Introduction
11.12.4 M20 Genomics Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.12.5 M20 Genomics Recent Development
11.13 Illumina
11.13.1 Illumina Company Details
11.13.2 Illumina Business Overview
11.13.3 Illumina Single-cell Transcriptome Sequencing Introduction
11.13.4 Illumina Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.13.5 Illumina Recent Development
11.14 QIAGEN
11.14.1 QIAGEN Company Details
11.14.2 QIAGEN Business Overview
11.14.3 QIAGEN Single-cell Transcriptome Sequencing Introduction
11.14.4 QIAGEN Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.14.5 QIAGEN Recent Development
11.15 Q2 Solutions
11.15.1 Q2 Solutions Company Details
11.15.2 Q2 Solutions Business Overview
11.15.3 Q2 Solutions Single-cell Transcriptome Sequencing Introduction
11.15.4 Q2 Solutions Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.15.5 Q2 Solutions Recent Development
11.16 Novogene
11.16.1 Novogene Company Details
11.16.2 Novogene Business Overview
11.16.3 Novogene Single-cell Transcriptome Sequencing Introduction
11.16.4 Novogene Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.16.5 Novogene Recent Development
11.17 Oxford Nanopore Technologies
11.17.1 Oxford Nanopore Technologies Company Details
11.17.2 Oxford Nanopore Technologies Business Overview
11.17.3 Oxford Nanopore Technologies Single-cell Transcriptome Sequencing Introduction
11.17.4 Oxford Nanopore Technologies Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.17.5 Oxford Nanopore Technologies Recent Development
11.18 PacBio
11.18.1 PacBio Company Details
11.18.2 PacBio Business Overview
11.18.3 PacBio Single-cell Transcriptome Sequencing Introduction
11.18.4 PacBio Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.18.5 PacBio Recent Development
11.19 Azenta Life Sciences
11.19.1 Azenta Life Sciences Company Details
11.19.2 Azenta Life Sciences Business Overview
11.19.3 Azenta Life Sciences Single-cell Transcriptome Sequencing Introduction
11.19.4 Azenta Life Sciences Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.19.5 Azenta Life Sciences Recent Development
11.20 Jingxin Biotechnology
11.20.1 Jingxin Biotechnology Company Details
11.20.2 Jingxin Biotechnology Business Overview
11.20.3 Jingxin Biotechnology Single-cell Transcriptome Sequencing Introduction
11.20.4 Jingxin Biotechnology Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.20.5 Jingxin Biotechnology Recent Development
11.21 TaKaRa
11.21.1 TaKaRa Company Details
11.21.2 TaKaRa Business Overview
11.21.3 TaKaRa Single-cell Transcriptome Sequencing Introduction
11.21.4 TaKaRa Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.21.5 TaKaRa Recent Development
11.22 Bio-Rad
11.22.1 Bio-Rad Company Details
11.22.2 Bio-Rad Business Overview
11.22.3 Bio-Rad Single-cell Transcriptome Sequencing Introduction
11.22.4 Bio-Rad Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.22.5 Bio-Rad Recent Development
11.23 Mission bio
11.23.1 Mission bio Company Details
11.23.2 Mission bio Business Overview
11.23.3 Mission bio Single-cell Transcriptome Sequencing Introduction
11.23.4 Mission bio Revenue in Single-cell Transcriptome Sequencing Business (2019-2024)
11.23.5 Mission bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Aksomics
10x Genomics
BD
BGI
Singleron Bio
Seekgene
ThunderBio
Tenk Genomics
MobiDrop
BioMarker
Dynamic Biosystems
M20 Genomics
Illumina
QIAGEN
Q2 Solutions
Novogene
Oxford Nanopore Technologies
PacBio
Azenta Life Sciences
Jingxin Biotechnology
TaKaRa
Bio-Rad
Mission bio
听
听
*If Applicable.
